UnitedHealth Group stock at EUR 332.70 with USD 338.3 billion market cap
Published on 10/08/2026 at 20:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- UnitedHealth Group stock was EUR 332.70 at Lang & Schwarz after-hours on October 8, 2026, down 0.86 percent versus EUR 335.60.
- The company had a USD 338.3 billion market capitalization and a P/E ratio of 23.96.
- UnitedHealth Group is scheduled to report third-quarter 2026 results before the market opens on October 13, 2026.
- Humana fell 2.31 percent and Elevance Health fell 0.14 percent on October 8, 2026, based on the same market-data timestamp.
UnitedHealth Group (ISIN US91324P1021) was at EUR 332.70 at Lang & Schwarz after-hours on October 8, 2026 at 8:03 p.m. CEST, down 0.86 percent versus the prior close of EUR 335.60. The company had a USD 338.3 billion market capitalization on the same date, giving the price report a clear valuation anchor.
Euro quote and US session
The bid was EUR 332.60 and the ask was EUR 332.80 at the Lang & Schwarz timestamp. On the NYSE, UnitedHealth Group was last at USD 372.49 on October 8, 2026 at 2:07 p.m. EDT, down 0.93 percent from USD 375.98.
The home-market quote and the German after-hours quote point in the same direction, but they remain separate currency observations. The NYSE session also recorded 2,071,013 shares in volume against an average of 4,909,037 shares, making turnover 57.70 percent of the average.
Range and valuation
The USD 255.97 to USD 461.62 52-week range places the NYSE price USD 89.13 below the high, or 19.31 percent below it, on October 8, 2026. The distance is calculated from the NYSE price and the same-currency 52-week high.
UnitedHealth Group carried a P/E ratio of 23.96 and a trailing dividend yield of 2.00 percent on October 8, 2026. Those figures place valuation and income metrics beside the market capitalization, without mixing them with the euro quote.
Comparison with peers
UnitedHealth Group: minus 0.86 percent, P/E 23.96, market capitalization USD 338.3 billion
Humana (NYSE, USD): minus 2.31 percent, P/E 36.64, market capitalization USD 46.5 billion
Elevance Health (NYSE, USD): minus 0.14 percent, P/E 17.94, market capitalization USD 87.6 billion
October 13 sets the next date
UnitedHealth Group said on September 15, 2026, that it will release third-quarter 2026 results before the market opens on October 13, 2026, followed by an 8:00 a.m. ET conference call. Zacks lists a consensus estimate of USD 4.12 for earnings per share for the quarter ending September 2026.
After-hours price remains the key marker
UnitedHealth Group's EUR 332.70 quote stood EUR 2.90 below its Lang & Schwarz prior close on October 8, 2026. The next company-specific calendar point is the October 13 results release, while the peer block shows a wider same-day decline at Humana than at UnitedHealth Group or Elevance Health.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group stock data
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 8, 2026, 8:03 p.m. CEST): EUR 332.70
- Change versus prior close: minus 0.86 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 335.60
- Market capitalization: USD 338.3 billion (as of October 8, 2026)
- 52-week range: USD 255.97-461.62 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Next earnings date: October 13, 2026
Market context: Market report S&P 500.
